Berlin, Germany

Hans Ahrens

This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1976.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hans Ahrens

Introduction

Hans Ahrens is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with therapeutic applications. His work has led to advancements in anti-inflammatory and antipyretic medications.

Latest Patents

Ahrens holds a patent for "Novel pyrazolyloxyacetic acid derivatives and process for the." This patent includes compounds of the formula where X and Y each are a bond or methylene, R is H or lower-alkyl, and Z is a carboxyl, amide, nitrile, or alkoxycarbonyl of 1-6 carbon atoms in the alkoxy group. The corresponding compounds bear 1-2 halogen, lower-alkyl, or lower-alkoxy groups on one or both benzene rings. When Z is carboxyl, the salts thereof with physiologically acceptable bases possess anti-inflammatory and antipyretic activities. Ahrens has 1 patent to his name.

Career Highlights

Hans Ahrens has worked at Schering Aktiengesellschaft, a prominent pharmaceutical company. His role has allowed him to engage in innovative research and development, contributing to the advancement of medical science.

Collaborations

Throughout his career, Ahrens has collaborated with esteemed colleagues such as Henning Koch and Eberhard Schroder. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Hans Ahrens is a distinguished inventor whose work in the field of chemistry has led to important advancements in therapeutic compounds. His contributions continue to influence the pharmaceutical industry and improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…